Clinical Trial Update: Transjugular Intrahepatic Portosystemic Shunts Improve Survival in Patients With Cirrhosis and Recurrent Ascites

View source ↗

Summary

A completed clinical trial suggests that transjugular intrahepatic portosystemic shunts (TIPS) improve survival in patients with cirrhosis and recurrent ascites…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Snippet

Sponsor: Tang-Du Hospital | Conditions: Refractory Ascites | Status: COMPLETED